1Prabhaswat P, Barton K, Burkett G, et al. Camparlson of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology, 1997, 104:974-985.
2Kim JS, Park JH, et al. Temporary amniotic membrane graft promotes healing and inhibits protease activity in corneal would induced by alkali burn in rabbits. Invest Ophthalmol Vis Sci, 1998, 39:9O.
3Seng SCG, Pranhasawat P, Lee SH. Amniotic mwmbrane transplantation for conjunctlval surface reconstruction. Am J Ophthaslmol, 1997, 124:765--774.
4Azuara BA, Pillai CT, Dua HS. Amniotic membrane transplandtation for ocular surface reconstruction. Br J Ophthalmol, 1999, 83 :399.
5Kruse FE, Joussen AM, Rohrschmeider K, et al. Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch Clin Esp Opthalmol, 2000, 2388:68.
6李凤鸣.眼科全书(第1版)[M].人民卫生出版社,1990.1319.
7Lin A, Stem G. Correlation between pterygium size and induced corneal astigmatism. Comea, 1998, 17 (1): 28.
9Lee AJ, Lee J. Saw SM. et al. Prevalence and risk factors associated with dry eye symptoms: a populalion based study in Indonesia. BrJ Ophthalmol, 2002, 86 (12): 1347-1351.
10Coroneo MT, Gimlamo ND, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol, 1999, 10 (4): 282- 288.
1J Frucht-Perry,F Raiskup,M Ilsar.Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence[].American Journal of Ophthalmology.2006
2Tanaka A, Chikama T, Harada D, et ah Outcome of conjunctival autograft with amniotic membrane transplantation for recurrent pte- rygium [ J ~. Nihon Ganka Gakkai Zasshi, 2011, 115 (4) : 386-390.
3Nava-Castaneda A, Ulloa-Orozco I, Garnica-Hayashi L, et al. Triple subconjunctival bevacizumab injection for early corneal recurrent pte- rygium: one-year follow-up [ J l. J Ocul Pharmacol Ther, 2014, 31 (2) :106-113.
